These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 27304608)

  • 1. Unusual serological findings associated with ceftriaxone-induced immune hemolytic anemia in a child with disseminated low-grade glioma.
    Pecker LH; Timsar A; Pary PP; Denomme GA; Criss VR; Luban NL; Hwang EI; Wong EC
    Pediatr Blood Cancer; 2016 Oct; 63(10):1852-5. PubMed ID: 27304608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ceftriaxone-induced hemolytic anemia in a child successfully managed with intravenous immunoglobulin.
    Vehapoğlu A; Göknar N; Tuna R; Çakır FB
    Turk J Pediatr; 2016; 58(2):216-219. PubMed ID: 27976566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ceftriaxone-induced immune hemolytic anemia.
    Neuman G; Boodhan S; Wurman I; Koren G; Bitnun A; Kirby-Allen M; Ito S
    Ann Pharmacother; 2014 Dec; 48(12):1594-604. PubMed ID: 25163809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serologic characteristics of ceftriaxone antibodies in 25 patients with drug-induced immune hemolytic anemia.
    Arndt PA; Leger RM; Garratty G
    Transfusion; 2012 Mar; 52(3):602-12. PubMed ID: 21880048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ceftriaxone-induced hemolytic anemia: case report and review of literature.
    Northrop MS; Agarwal HS
    J Pediatr Hematol Oncol; 2015 Jan; 37(1):e63-6. PubMed ID: 24878619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravascular haemolysis in a patient on ceftriaxone with demonstration of anticeftriaxone antibodies.
    Dinesh D; Dugan N; Carter J
    Intern Med J; 2008 Jun; 38(6):438-41. PubMed ID: 18613898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe ceftriaxone-induced hemolysis complicated by diffuse cerebral ischemia in a child with sickle cell disease.
    Schuettpelz LG; Behrens D; Goldsmith MI; Druley TE
    J Pediatr Hematol Oncol; 2009 Nov; 31(11):870-2. PubMed ID: 19829151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of acute hemolysis after ceftriaxone: immune complex mechanism demonstrated by flow cytometry.
    Kakaiya R; Cseri J; Smith S; Silberman S; Rubinas TC; Hoffstadter A
    Arch Pathol Lab Med; 2004 Aug; 128(8):905-7. PubMed ID: 15270609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemolysis from ceftriaxone.
    Med Lett Drugs Ther; 2002 Nov; 44(1144):100-1. PubMed ID: 12451362
    [No Abstract]   [Full Text] [Related]  

  • 10. Ceftriaxone-induced immune hemolytic anemia as a life-threatening complication of antibiotic treatment of 'chronic Lyme disease'.
    De Wilde M; Speeckaert M; Callens R; Van Biesen W
    Acta Clin Belg; 2017 Apr; 72(2):133-137. PubMed ID: 27169474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatal hemolysis induced by ceftriaxone in a child with sickle cell anemia.
    Bernini JC; Mustafa MM; Sutor LJ; Buchanan GR
    J Pediatr; 1995 May; 126(5 Pt 1):813-5. PubMed ID: 7752012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe hemolytic crisis after ceftriaxone administration.
    Goyal M; Donoghue A; Schwab S; Hasbrouck N; Khojasteh S; Osterhoudt K
    Pediatr Emerg Care; 2011 Apr; 27(4):322-3. PubMed ID: 21467885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe immune haemolytic anaemia due to ceftriaxone in a patient with congenital nephrotic syndrome.
    Reis Boto ML; Sandes AR; Brites A; Silva S; Stone R; Almeida M
    Acta Paediatr; 2011 Oct; 100(10):e191-3. PubMed ID: 21450013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ceftriaxone-induced hemolytic anemia with severe renal failure: a case report and review of literature.
    Leicht HB; Weinig E; Mayer B; Viebahn J; Geier A; Rau M
    BMC Pharmacol Toxicol; 2018 Oct; 19(1):67. PubMed ID: 30359322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatal immune haemolysis due to a degradation product of ceftriaxone.
    Meyer O; Hackstein H; Hoppe B; Göbel FJ; Bein G; Salama A
    Br J Haematol; 1999 Jun; 105(4):1084-5. PubMed ID: 10554824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune hemolytic anemia with drug-induced antibodies to carboplatin and vincristine in a pediatric patient with an optic pathway glioma.
    Betensky M; Witmer C; Fisher MJ; Nance S; Weiss MJ; Sesok-Pizzini DA
    Transfusion; 2014 Nov; 54(11):2901-5. PubMed ID: 24860959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ceftriaxone induced immune hemolytic anemia: detection of drug-dependent antibody by ex-vivo antigen in urine.
    Kim S; Song KS; Kim HO; Lee HM
    Yonsei Med J; 2002 Jun; 43(3):391-4. PubMed ID: 12089751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ceftriaxone-Induced Hemolytic Anemia in a Jehovah's Witness.
    Tasch J; Gonzalez-Zayaz P
    Am J Case Rep; 2017 Apr; 18():431-435. PubMed ID: 28428532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ceftriaxone-induced hemolysis in an adult.
    Falezza GC; Piccoli PL; Franchini M; Gandini G; Aprili G
    Transfusion; 2000 Dec; 40(12):1543-5. PubMed ID: 11134579
    [No Abstract]   [Full Text] [Related]  

  • 20. Serology of antibodies to second- and third-generation cephalosporins associated with immune hemolytic anemia and/or positive direct antiglobulin tests.
    Arndt PA; Leger RM; Garratty G
    Transfusion; 1999; 39(11-12):1239-46. PubMed ID: 10604252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.